MacroGenics is pursuing alliances to participate in development of its proprietary product candidates and technology platforms.
Learn moreSince its founding in 2000, MacroGenics has applied its world-class antibody capabilities to create life-changing medicines. The company’s innovative product candidates leverage its fully-integrated capabilities and its multiple, proprietary technology platforms.
Learn more 2006 News Archive
July 31, 2006 | The Washington Post
3 Big Deals Push Venture Funding To 4-Year Peak
May 17, 2006 | Washington Business Journal
MacroGenics Raises $45M In Third Round Of Funding
News Archive: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | View All